Can exogenous steroid precursors raise DHEA-S or progesterone and increase downstream androgen exposure?

Exogenous steroid precursors and hormone-containing products can plausibly account for concurrent elevations in DHEA-S and progesterone measurements, while also altering downstream androgen exposure. This is particularly relevant when interpreting an unexpected steroid profile in a 52-year-old man.

Clinical and biochemical evidence

• Oral pregnenolone (500 mg/day for 4 weeks) increased serum DHEA-S by approximately 16% in a small human pilot and was associated with a greater-than-fourfold increase in measured progesterone.
• Oral DHEA reliably raises DHEA-S; in older men, supplementation restored concentrations toward those seen in younger adults.
• A meta-analysis of 42 publications (55 randomized-trial arms) found DHEA increased total testosterone by a mean 28.0 ng/dL. Effects were larger in women and at doses >50 mg/day; in older men, 50 mg/day for four months restored DHEA-S without a significant circulating-androgen increase.

Mechanistic and assay considerations

• DHEA is a steroid precursor that can undergo peripheral conversion to androstenedione, testosterone, and sometimes DHT, but conversion varies by dose, sex, tissue enzymatic activity, and individual physiology.
• This should not be generalized to every precursor: controlled studies did not find reliable testosterone increases with androstenedione or with pregnenolone over 8 weeks.
• Importantly, DHEA-S can cross-react with some progesterone immunoassays. Thus, a high DHEA-S may produce an apparently high progesterone result even without an equivalent true progesterone elevation. The pregnenolone progesterone finding, measured by radioimmunoassay, could reflect true conversion, interference, or both.

Practical implications

• A complete history should include DHEA, pregnenolone, “hormone boosters,” compounded/bioidentical products, prescribed progesterone or progestins, and topical preparations—plus dose, route, and timing relative to blood draw.
• Unexpected progesterone elevation should be confirmed by LC–MS/MS when possible; persistent confirmed abnormalities merit clinical assessment.

Bottom line

• Supplement or exogenous-hormone exposure is a clinically important potential explanation when both DHEA-S and progesterone are high, but the androgenic and progesterone effects are product- and assay-dependent rather than universal.